Ahmedabad, India-based Lambda Therapeutic Research Limited will acquire Pittsburgh, PA-based Novum Pharmaceutical Research Services for an undisclosed amount. Following the transaction, Novum will continue to operate as a wholly-owned subsidiary of Lambda.
Tausif Monif, president of global operations at Lambda, said that the company aims to broaden the scope of its offerings by providing its expertise in pharmacovigilance, large molecular trials, immunogenicity testing, and bioanalytical services.
India’s drug makers have been active in acquiring companies in the U.S. to enter or strengthen their presence in the world’s largest pharmaceutical market.
Last updated: December 26th, 2025
